The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Matching-adjusted indirect comparison of fruquintinib versus ramucirumab in advanced gastric or gastroesophageal junction adenocarcinoma.
 
Nan An
No Relationships to Disclose
 
Jiaying Chen
No Relationships to Disclose
 
Jibin Li
No Relationships to Disclose
 
Lin Shen
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; MSD; SERVIER; Transcenta Holding Limited
Research Funding - BeiGene (Inst)
 
Weijian Guo
No Relationships to Disclose
 
Tianshu Liu
No Relationships to Disclose
 
Jin Li
No Relationships to Disclose
 
Shukui Qin
No Relationships to Disclose
 
Yuxian Bai
No Relationships to Disclose
 
Zhendong Chen
No Relationships to Disclose
 
Jufeng Wang
No Relationships to Disclose
 
Yueyin Pan
No Relationships to Disclose
 
Ruihua Xu
No Relationships to Disclose
 
Feng Wang
No Relationships to Disclose